file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 84164, GCS 458115, CR 564869 Collection span: 1953 - 2011 | |
| Word(i) List (11332) Word count: 98751, All words count: 141482 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 451 | CYTOPLASMIC | 39 | 161 | 1329 |
| 452 | RENAL | 26 | 138 | 1328 |
| 453 | TURNOVER | 28 | 133 | 1328 |
| 454 | PREPARATION | 31 | 301 | 1326 |
| 455 | ACCELERATED | 32 | 170 | 1325 |
| 456 | ADULTS | 51 | 202 | 1323 |
| 457 | PULMONARY | 36 | 50 | 1320 |
| 458 | PRECURSOR | 22 | 80 | 1318 |
| 459 | MUTANT | 27 | 226 | 1311 |
| 460 | PHYSICAL | 47 | 123 | 1310 |
| 461 | IMMUNOLOGICAL | 28 | 202 | 1309 |
| 462 | AORTIC | 22 | 88 | 1305 |
| 463 | INCREASE | 46 | 298 | 1303 |
| 464 | SENSITIVITY | 52 | 181 | 1302 |
| 465 | WERNER | 40 | 375 | 1299 |
| 466 | MELANOMA | 35 | 46 | 1298 |
| 467 | INDUCE | 30 | 279 | 1297 |
| 468 | INDUCIBLE | 20 | 158 | 1295 |
| 469 | INACTIVATION | 24 | 338 | 1291 |
| 470 | SCREEN | 4 | 270 | 1287 |
| 471 | STRUCTURAL | 30 | 103 | 1286 |
| 472 | TEMPLATE | 11 | 445 | 1285 |
| 473 | STATES | 32 | 645 | 1283 |
| 474 | EXTENDED | 18 | 389 | 1282 |
| 475 | RESEARCH | 114 | 236 | 1282 |
| 476 | ADENOSINE | 29 | 104 | 1279 |
| 477 | DECREASE | 33 | 130 | 1275 |
| 478 | FAMILY | 31 | 178 | 1273 |
| 479 | HEALTH | 100 | 69 | 1271 |
| 480 | TRANSPORT | 33 | 73 | 1270 |
| # | Word | Recs | TLCS | TGCS |
| 481 | ADENOCARCINOMA | 15 | 28 | 1265 |
| 482 | INHIBITS | 22 | 221 | 1259 |
| 483 | I125 | 1 | 15 | 1257 |
| 484 | RESTRICTION | 38 | 166 | 1255 |
| 485 | DEFICIENT | 38 | 115 | 1254 |
| 486 | FREQUENCY | 31 | 298 | 1253 |
| 487 | HEST2 | 1 | 166 | 1250 |
| 488 | DEFINED | 22 | 79 | 1248 |
| 489 | OBSERVATIONS | 40 | 271 | 1243 |
| 490 | PHOSPHATE | 32 | 120 | 1237 |
| 491 | LEVEL | 45 | 290 | 1236 |
| 492 | ARTHRITIS | 41 | 247 | 1235 |
| 493 | STROMAL | 32 | 146 | 1234 |
| 494 | DEOXYRIBONUCLEIC | 23 | 179 | 1232 |
| 495 | BILAYERS | 7 | 41 | 1227 |
| 496 | MESSENGER | 34 | 237 | 1226 |
| 497 | IMPORTANCE | 26 | 107 | 1225 |
| 498 | TEMPERATURE | 46 | 186 | 1225 |
| 499 | SKELETAL | 22 | 75 | 1221 |
| 500 | QUIESCENT | 24 | 260 | 1220 |
| 501 | INVOLVEMENT | 21 | 349 | 1218 |
| 502 | SEROLOGICAL | 36 | 317 | 1218 |
| 503 | THEORIES | 28 | 382 | 1218 |
| 504 | SARCOMA | 37 | 141 | 1216 |
| 505 | GLUCOSE | 51 | 191 | 1211 |
| 506 | MALE | 24 | 65 | 1211 |
| 507 | EPITHELIUM | 31 | 186 | 1209 |
| 508 | RISK | 76 | 65 | 1205 |
| 509 | ABILITY | 29 | 250 | 1204 |
| 510 | DIFFERENTIATED | 17 | 54 | 1200 |
| # | Word | Recs | TLCS | TGCS |
| 511 | DISEASES | 80 | 187 | 1199 |
| 512 | MORPHOLOGICAL | 50 | 351 | 1194 |
| 513 | CHAIN | 29 | 90 | 1193 |
| 514 | INVOLVED | 35 | 331 | 1191 |
| 515 | TARGET | 24 | 200 | 1191 |
| 516 | ALLOGRAFT | 16 | 62 | 1190 |
| 517 | CLONED | 25 | 127 | 1189 |
| 518 | HYDROCARBONS | 10 | 81 | 1189 |
| 519 | EPIGENETIC | 32 | 122 | 1186 |
| 520 | FIBRONECTIN | 24 | 181 | 1186 |
| 521 | CIP1 | 22 | 319 | 1185 |
| 522 | HEAT | 30 | 193 | 1185 |
| 523 | REVERSE | 25 | 71 | 1185 |
| 524 | AGAR | 26 | 323 | 1184 |
| 525 | CURRENT | 45 | 299 | 1183 |
| 526 | DYNAMICS | 45 | 237 | 1183 |
| 527 | CONSTITUTIVE | 12 | 202 | 1176 |
| 528 | LABELS | 11 | 176 | 1167 |
| 529 | SHOCK | 19 | 229 | 1166 |
| 530 | PROGENITOR | 37 | 64 | 1164 |
| 531 | PROTECTS | 9 | 154 | 1164 |
| 532 | PHOSPHOLIPID | 13 | 47 | 1159 |
| 533 | TYPES | 25 | 94 | 1152 |
| 534 | EXTENSIVE | 7 | 48 | 1149 |
| 535 | VASCULAR | 47 | 129 | 1148 |
| 536 | PRODUCTS | 30 | 141 | 1147 |
| 537 | MONOLAYER | 31 | 122 | 1146 |
| 538 | OCCURRENCE | 23 | 167 | 1144 |
| 539 | TUMORS | 43 | 208 | 1141 |
| 540 | REPRESSION | 13 | 363 | 1139 |
| # | Word | Recs | TLCS | TGCS |
| 541 | PLEUROPNEUMONIA | 34 | 593 | 1135 |
| 542 | THYROID | 26 | 59 | 1131 |
| 543 | ALVEOLAR | 20 | 38 | 1129 |
| 544 | WIDESPREAD | 3 | 23 | 1129 |
| 545 | WHOLE | 8 | 147 | 1127 |
| 546 | IMR | 32 | 471 | 1124 |
| 547 | MYOGENIC | 6 | 31 | 1123 |
| 548 | CALCIUM | 17 | 37 | 1121 |
| 549 | MICRONUCLEI | 3 | 4 | 1121 |
| 550 | EXPOSURE | 38 | 195 | 1120 |
| 551 | MUTAGENESIS | 18 | 87 | 1119 |
| 552 | FEATURES | 24 | 177 | 1118 |
| 553 | RUBELLA | 40 | 118 | 1114 |
| 554 | REDUCTION | 47 | 178 | 1111 |
| 555 | GENOTYPE | 7 | 688 | 1110 |
| 556 | DECREASED | 35 | 216 | 1106 |
| 557 | RETENTION | 4 | 22 | 1104 |
| 558 | DIABETES | 46 | 233 | 1103 |
| 559 | TERMINAL | 21 | 268 | 1101 |
| 560 | MICROBIAL | 14 | 7 | 1097 |
| 561 | CONTENT | 41 | 312 | 1094 |
| 562 | COMPLEX | 34 | 53 | 1092 |
| 563 | CD8 | 20 | 69 | 1090 |
| 564 | CHOLESTEROL | 35 | 102 | 1090 |
| 565 | VACCINE | 56 | 195 | 1090 |
| 566 | SIZE | 36 | 496 | 1087 |
| 567 | RADICAL | 22 | 65 | 1080 |
| 568 | DEVELOPMENTAL | 32 | 26 | 1079 |
| 569 | PIGMENTOSUM | 19 | 117 | 1079 |
| 570 | XERODERMA | 19 | 117 | 1079 |
| # | Word | Recs | TLCS | TGCS |
| 571 | MACROPHAGES | 24 | 73 | 1078 |
| 572 | HETEROCHROMATIN | 13 | 247 | 1076 |
| 573 | PHOSPHATASE | 39 | 76 | 1076 |
| 574 | WAF1 | 22 | 269 | 1074 |
| 575 | GROUP | 42 | 192 | 1070 |
| 576 | PATIENT | 36 | 64 | 1068 |
| 577 | STABILITY | 49 | 152 | 1068 |
| 578 | LATE | 37 | 403 | 1067 |
| 579 | TOXICITY | 39 | 51 | 1067 |
| 580 | PROGRAMMED | 17 | 140 | 1066 |
| 581 | LEADS | 11 | 270 | 1064 |
| 582 | LIMITS | 17 | 175 | 1064 |
| 583 | TYROSINE | 15 | 102 | 1064 |
| 584 | RECONSTITUTION | 7 | 236 | 1063 |
| 585 | STIMULATED | 39 | 167 | 1063 |
| 586 | GENOMIC | 34 | 141 | 1060 |
| 587 | OSTEOGENIC | 8 | 28 | 1060 |
| 588 | SYSTEMS | 61 | 95 | 1058 |
| 589 | GLYCOPROTEIN | 14 | 22 | 1057 |
| 590 | ORGANIZATION | 25 | 115 | 1057 |
| 591 | SILENCING | 8 | 217 | 1054 |
| 592 | MARGINOTOMY | 3 | 421 | 1051 |
| 593 | CHONDROCYTES | 33 | 88 | 1050 |
| 594 | ALTERATION | 35 | 261 | 1047 |
| 595 | POLYNUCLEOTIDES | 3 | 412 | 1044 |
| 596 | BIOSYNTHESIS | 32 | 111 | 1043 |
| 597 | ARTIFICIAL | 12 | 937 | 1041 |
| 598 | LYSOSOMAL | 24 | 197 | 1040 |
| 599 | SUPEROXIDE | 18 | 57 | 1038 |
| 600 | CONDITIONS | 40 | 249 | 1035 |